Jevity Advance is a 1.5kcal/ml, nutritionally complete† tube feed with FOS (fructo-oligosaccharides), and a unique blend of high protein, additional vitamin D and CaHMB (calcium-β-hydroxy-β-methylbutyrate). Jevity Advance is available in 500 ml Ready to Hang bottles, which attach directly to Abbott giving sets.
SUITABLE FOR KOSHER DIET | SUITABLE FOR HALAL DIET | SUITABLE FOR VEGETARIAN DIET | GLUTEN FREE |
√ | √ | √* | √ |
* Vitamin D is synthesised from cholesterol, extracted from the grease in wool sheared from live sheep.
† Nutritionally complete for vitamins and minerals in 1111 ml (excluding electrolytes, calculated using the UK Reference Nutrient Intake for men aged 19-50 years).
Jevity Advance is a Food for Special Medical Purposes, for use under medical supervision
PER 100 ML | PER 500 ML | PER 1000 ML | |
---|---|---|---|
Energy | 631 kJ / 150 kcal | 3153 kJ / 750 kcal | 6306 kJ / 1500 kcal |
Protein | 8.00 g | 40.0 g | 80.0 g |
Fibre | 0.75 g | 3.75 g | 7.5 g |
of which FOS | 0.75 g | 3.75 g | 7.5 g |
Ensure Compact is a 125 ml, ready-to-drink, nutritionally complete§ oral nutritional supplement for people with, or at risk of developing, disease-related malnutrition. Its small volume has been specially developed for people who have difficulty drinking larger volumes or who have a poor appetite. Each easy-to-open Ensure Compact bottle1 provides 300 kcal (2.4 kcal/ml) and 12.8 g of protein. Ensure Compact is available in 4 delicious flavours; banana, café latte, strawberry and vanilla. §Nutritionally complete for vitamins and minerals in 625 ml (excluding sodium, potassium, chloride and magnesium). Calculated using the UK Reference Nutrient Intake for men aged 19-50 years.
Ensure Plus Advance is a 220 ml, ready-to-drink, oral nutritional supplement (ONS) formulated specifically for older adults who have, or are at risk of, malnutrition. It’s our most advanced ONS yet, with each bottle providing 330 kcal (1.5 kcal/ml), 20 g of protein, 13 μg of vitamin D (500 IU), 499 mg of calcium and 1.5g of CaHMB (calcium-β-hydroxy-β-methylbutyrate). Ensure Plus Advance is available in 5 delicious flavours: banana, chocolate, coffee, strawberry and vanilla.
Ensure Plus juce is a 1.5 kcal/ml, ready-to-drink, juice style oral nutritional supplement for people with, or at risk of developing, disease-related malnutrition. Ensure Plus juce is best served chilled and is available in six flavours: apple, fruit punch, lemon and lime, orange, peach and strawberry. It's presented in a 220 ml bottle with a peel-off seal for pouring.
Implications of Low Muscle Mass Across the Continuum of Care
This narrative, published in the 15 November 2018 issue of The Annals of Medicine, provides an overview of the implications of low muscle mass on healthy outcomes for patients in inpatient, outpatient and long-term care clinical settings.
The value of muscle in improving clinical outcomes
This article discusses the importance of muscle mass in improving clinical outcomes and quality of life. There is a need to change the current malnutrition management approach from a focus on weight to targeting muscle mass. Screening tools should include assessment of muscle mass, and there should be a focus on the maintenance of muscle mass as a malnutrition management strategy.
Muscle loss, malnutrition, frailty, Nourish, over 65, aging, Patients Association, thin, frail, muscle strength, nutrition, nutritional supplements, I‐CARE
Muscle loss is a common sign of frailty and almost a third of the UK adult population believe becoming thin and frail is an unavoidable part of growing old. As a result, there is a fear of illness and dependence.1
Arnold is an 82 year old male patient with a ruptured oesphagus and dysphagia.
Abbott’s nutrition business in the UK works in partnership with Vitaflo International Ltd. to provide selected products for the management of disease-related malnutrition.
UK-N/A-2300090 | March 2023
You are about to exit for another Abbott country or region specific website.
Please be aware that the website you have requested is intended for the residents of a particular country or region, as noted on that site. As a result, the site may contain information on pharmaceuticals, medical devices and other products or uses of those products that are not approved in other countries or regions.
The website you have requested also may not be optimised for your specific screen size.
Do you wish to continue and exit this website?
UK-N/A-2200465 | July 2022
UK-N/A-2200443 | June 2022
Stay Connected